FBLGFibroBiologics, Inc.vs its industry peers
A metric-by-metric comparison of FibroBiologics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLGEsta | $6M#2 | 0.3x#1 | 1.4x#6 | — | — | -67.1%#8 | — | -402.2%#7 | -1409.7%#5 | — | — | — |
| VTGN | $7M#1 | — | 0.3x#2 | 5.9x#4 | 161.1%#1 | -35.5%#7 | -5683.7%#4 | -284.7%#6 | -949.7%#4 | — | — | — |
| ENVB | $6M#4 | — | 0.8x#4 | 0.2x#1 | -7.2%#3 | 26.0%#5 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#1 | — | — |
| XCUR | $6M#3 | — | 6.6x#8 | — | -100.0%#5 | 49.0%#2 | — | -506.2%#8 | — | — | — | — |
| APRE | $6M#5 | — | 0.2x#1 | — | — | 2.8%#6 | — | -32.8%#2 | — | — | — | — |
| ALZN | $6M#6 | — | 1.1x#5 | — | — | -94.3%#9 | — | -151.2%#4 | — | — | — | — |
| PRPH | $6M#7 | — | — | 1.3x#3 | -35.8%#4 | 72.4%#1 | -415.4%#3 | — | -804.6%#3 | — | — | — |
| ACXP | $5M#8 | — | 0.7x#3 | — | — | 43.5%#4 | — | -97.7%#3 | — | — | — | — |
| PULM | $5M#9 | — | 2.1x#7 | 0.7x#2 | 7.0%#2 | 46.0%#3 | -66.2%#2 | -201.9%#5 | -235.7%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice